Table 1.
Patient characteristics
| Patients | n |
| Male, % | 846, 60% |
| Age, median (range) | 73 (12-99) |
| Native papilla | 668, 47.6% |
| Indication | |
| Malignancy | 522 |
| Choledocholithiasis | 771 |
| Others | 110 |
| Cannulation time, median (range) | 5 min (1-185) |
| Procedure time, median | 37 min (3-185) |
| 2 h amylase | 97 IU/mL (10-3502) |
| median (range) | |
| ERCP and related procedures | |
| Total ERCP | 1403 |
| ENBD | 362 |
| EBS | 380 |
| EMS | 42 |
| EPS | 124 |
| Precut | 35 |
| EST | 505 |
| EPBD | 20 |
| EPLBD | 38 |
| Pancreatic duct brush | 15 |
ERCP: Endoscopic retrograde cholangiopancreatography; EBS: Endoscopic biliary stent; EMS: Endoscopic metallic stent; EPS: Endoscopic pancreatic stent; EST: Endoscopic sphincterotomy; EPBD: Endoscopic papillary balloon dilation; EPLBD: Endoscopic papillary large balloon dilation; ENBD: Endoscopic nasobiliary drainage.